Device / Technology News

RSS

Cerner, Fort HealthCare collaborate to create connected health community

Cerner Corporation announced a strategic partnership with Fort HealthCare, an integrated hospital and health system in Fort Atkinson, Wis., to create a connected health community. Fort HealthCare will work with Cerner to improve the quality of care and make care processes more efficient for more than 120,000 residents in the organization's service area through the use of Cerner Millennium® solutions.

4 May 2010

Theragenics reports highest quarterly consolidated revenue of $20.3 million

Theragenics Corporation®, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the first quarter ended March 31, 2010.

4 May 2010

Aethlon Medical plans to initiate patient recruitment for cancer immunotherapy study

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it plans to initiate patient recruitment for a cancer immunotherapy study by year end. The pilot study seeks to demonstrate an improved immune function in cancer patients as a result of the Aethlon Hemopurifier removing tumor-secreted exosomes from the circulatory system.

4 May 2010

HPV test recommended for national cervical cancer screening programmes

Two studies suggest that testing for the human papillomavirus (HPV) - the major cause of cervical cancer - could be used in national cervical cancer screening programmes.

4 May 2010

Amorfix Life Sciences detects AD-associated aggregated Beta-amyloid in blood plasma

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases such as Alzheimer's disease (AD), announced today the detection of the AD-associated aggregated Beta-amyloid (ABeta), the hallmark of AD, in the blood from the most-frequently-used animal model of AD. The assay detects both oligomeric and fibrillar aggregates of ABeta, which are generally considered to be the toxic forms and major contributors to brain dysfunction in AD.

4 May 2010

MicroStockProfit.com releases Hansen Medical investment report

MicroStockProfit.com announces an investment report featuring Hansen Medical Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

4 May 2010

JNM supplement examines advances in cardiovascular molecular imaging

The Journal of Nuclear Medicine -the top-rated medical imaging journal worldwide-has published Multimodality Molecular Imaging of the Cardiovascular System, presenting the state of the art of cardiovascular molecular imaging and discussing opportunities and challenges in advancing cardiovascular molecular imaging to clinical practice.

4 May 2010

FDA grants market clearance for Illumina's BeadXpress system for multiplex genetic analysis

Illumina, Inc. today announced that the U.S. Food and Drug Administration has granted 510(k) market clearance for the company's BeadXpress system for multiplex genetic analysis.

From Illumina, Inc. 4 May 2010

Merci Retriever receives Shonin approval in Japan

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that the Merci Retriever, Merci Microcatheter, and Merci Balloon Guide Catheter have received Shonin approval in Japan.

4 May 2010

Kaiser Permanente introduces Sustainability Scorecard for medical equipment, products

Kaiser Permanente, committed to improving the health of its patients, workforce and communities, announced today that it will require suppliers to provide environmental data for $1 billion worth of medical equipment and products used in its hospitals, medical offices and other facilities.

4 May 2010

Alnylam Biotherapeutics presents new data on RNAi technologies at Cell Culture Engineering XII

Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the Cell Culture Engineering XII conference held in Alberta, Canada from April 25 - 30, 2010. Alnylam Biotherapeutics was formed by Alnylam to develop RNAi technologies for application in manufacturing processes for biotherapeutic products, including recombinant proteins and monoclonal antibodies.

4 May 2010

Study comparing enteroscopy technologies finds SE quicker than DBE for examining small intestine

Spirus Medical, Inc., a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, announced at Digestive Disease Week 2010 that results from the first-ever prospective study comparing enteroscopy technologies show spiral enteroscopy (SE) to be more than three times faster, on average, than double-balloon enteroscopy (DBE) in examining the small intestine.

4 May 2010

Surgeons can now customize artificial knee implants, prevent future revision surgeries

Throughout the years orthopedic surgeons have learned that one size does not fit all when it comes to joint replacements. Because of advancements in technology, surgeons can now customize artificial knee implants and prevent future revision surgeries.

4 May 2010

Wellstar International commences second Beta Test in Long Term Care Facility

Wellstar International Inc. has announced they have started their second Beta Test in a Long Term Care Facility.

4 May 2010

Schepens Eye Research Institute scientist selected for Otto Schade Prize

Dr. Eli Peli, a senior scientist at Schepens Eye Research Institute, has been selected by the Society for Information Display for the Otto Schade Prize. Peli will receive the award at a special presentation at the Society's Awards Banquet on May 24, 2010 in Seattle.

4 May 2010

Researchers explore role of ECoG measurement to improve brain mapping technology

Epilepsy and seizures affect nearly 3 million Americans of all ages, with 200,000 new cases of seizures and epilepsy occurring each year. Epilepsy surgery may be performed in patients who have seizures associated with structural brain abnormalities, such as benign brain tumors and cortical dysplasia, malformations of blood vessels, the genetic disorder tuberous sclerosis, and strokes.

4 May 2010

Novel biomarker test predicts risk of disease progression in patients with Crohn's disease

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced new findings supporting a novel, algorithm-based biomarker test that helps clinicians effectively predict the risk of developing aggressive disease in patients with Crohn's disease.

4 May 2010

First of 5 Grand Challenges: Create point-of-care tools to diagnose range of illnesses

The Hon. James Flaherty, Minister of Finance for Canada, today announced the launch of Grand Challenges Canada, an innovative initiative that will help redefine Canada's role in the developing world by bringing together Canadian scientists, developing world scientific researchers, and the private sector to solve some of the most persistent health challenges facing poor countries.

4 May 2010

FDA orders Baxter Healthcare to recall and destroy all Colleague infusion pumps

The U.S. Food and Drug Administration sent a letter to Baxter Healthcare Corp. on April 30 ordering the company to recall and destroy all of its Colleague Volumetric Infusion Pumps (Colleague pumps) currently in use in the United States. This action is based on a longstanding failure to correct many serious problems with the pumps. The FDA believes there may be as many as 200,000 of those pumps currently in use.

4 May 2010

Brain changes indicative of Fragile X syndrome take place early

Brain changes associated with the most common cause of mental retardation can be seen in magnetic resonance imaging (MRI) scans of children as young as one to three years old, according to a study by researchers at the University of North Carolina at Chapel Hill and Stanford University.

4 May 2010

Device / Technology News

Cerner, Fort HealthCare collaborate to create connected health community

Theragenics reports highest quarterly consolidated revenue of $20.3 million

Aethlon Medical plans to initiate patient recruitment for cancer immunotherapy study

HPV test recommended for national cervical cancer screening programmes

Amorfix Life Sciences detects AD-associated aggregated Beta-amyloid in blood plasma

MicroStockProfit.com releases Hansen Medical investment report

JNM supplement examines advances in cardiovascular molecular imaging

FDA grants market clearance for Illumina's BeadXpress system for multiplex genetic analysis

Merci Retriever receives Shonin approval in Japan

Kaiser Permanente introduces Sustainability Scorecard for medical equipment, products

Alnylam Biotherapeutics presents new data on RNAi technologies at Cell Culture Engineering XII

Study comparing enteroscopy technologies finds SE quicker than DBE for examining small intestine

Surgeons can now customize artificial knee implants, prevent future revision surgeries

Wellstar International commences second Beta Test in Long Term Care Facility

Schepens Eye Research Institute scientist selected for Otto Schade Prize

Researchers explore role of ECoG measurement to improve brain mapping technology

Novel biomarker test predicts risk of disease progression in patients with Crohn's disease

First of 5 Grand Challenges: Create point-of-care tools to diagnose range of illnesses

FDA orders Baxter Healthcare to recall and destroy all Colleague infusion pumps

Brain changes indicative of Fragile X syndrome take place early

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News